Vitamin Blue Revenue vs. EBITDA

VTMB Stock  USD 0.0001  0.00  0.00%   
Based on the measurements of profitability obtained from Vitamin Blue's financial statements, Vitamin Blue may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in May. Profitability indicators assess Vitamin Blue's ability to earn profits and add value for shareholders.
For Vitamin Blue profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Vitamin Blue to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Vitamin Blue utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Vitamin Blue's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Vitamin Blue over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
Please note, there is a significant difference between Vitamin Blue's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vitamin Blue is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vitamin Blue's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Vitamin Blue EBITDA vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Vitamin Blue's current stock value. Our valuation model uses many indicators to compare Vitamin Blue value to that of its competitors to determine the firm's financial worth.
Vitamin Blue is rated first in revenue category among related companies. It is rated first in ebitda category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Vitamin Blue by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vitamin Blue's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vitamin Blue's earnings, one of the primary drivers of an investment's value.

Vitamin Revenue vs. Competition

Vitamin Blue is rated first in revenue category among related companies. Market size based on revenue of Leisure industry is at this time estimated at about 21.49 Billion. Vitamin Blue adds roughly 250,027 in revenue claiming only tiny portion of all equities under Leisure industry.

Vitamin EBITDA vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Vitamin Blue

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
250.03 K
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Vitamin Blue

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(112.37 K)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Vitamin EBITDA Comparison

Vitamin Blue is currently under evaluation in ebitda category among related companies.

Vitamin Blue Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Vitamin Blue, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Vitamin Blue will eventually generate negative long term returns. The profitability progress is the general direction of Vitamin Blue's change in net profit over the period of time. It can combine multiple indicators of Vitamin Blue, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Vitamin Blue, Inc. designs, develops, produces, and distributes water boardsports apparel and related products primarily in the United States. Vitamin Blue, Inc. was founded in 1999 and is based in Costa Mesa, California. Vitamin Blue operates under Leisure classification in the United States and is traded on OTC Exchange. It employs 1 people.

Vitamin Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Vitamin Blue. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Vitamin Blue position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Vitamin Blue's important profitability drivers and their relationship over time.

Use Vitamin Blue in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vitamin Blue position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vitamin Blue will appreciate offsetting losses from the drop in the long position's value.

Vitamin Blue Pair Trading

Vitamin Blue Pair Trading Analysis

The ability to find closely correlated positions to Vitamin Blue could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vitamin Blue when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vitamin Blue - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vitamin Blue to buy it.
The correlation of Vitamin Blue is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vitamin Blue moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vitamin Blue moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vitamin Blue can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Vitamin Blue position

In addition to having Vitamin Blue in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Government Funds Thematic Idea Now

Government Funds
Government Funds Theme
Funds or Etfs that invest in fixed income securities issued by national government to finance government spending or to facilitate Federal Reserve monetary policies. The Government Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Government Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Vitamin Pink Sheet analysis

When running Vitamin Blue's price analysis, check to measure Vitamin Blue's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitamin Blue is operating at the current time. Most of Vitamin Blue's value examination focuses on studying past and present price action to predict the probability of Vitamin Blue's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitamin Blue's price. Additionally, you may evaluate how the addition of Vitamin Blue to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
To fully project Vitamin Blue's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Vitamin Blue at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Vitamin Blue's income statement, its balance sheet, and the statement of cash flows.
Potential Vitamin Blue investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Vitamin Blue investors may work on each financial statement separately, they are all related. The changes in Vitamin Blue's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Vitamin Blue's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.